Navigation Links
New Vaccine To Combat The Deadly Marburg Virus

The study team involving researchers from the U.S. Army Medical Research Institute of Infectious Diseases and the National Microbiology Laboratory// at the Public Health Agency of Canada reported yesterday that the vaccine that is used to protect monkeys by in preventing hemorrhagic fever in monkeys after they were exposed to the deadly Marburg virus. Could also provide the first known treatment for the infection caused by Ebola virus.

The researchers now claim that they have created a vaccine by replacing a gene from a harmless virus with a gene encoding a surface protein on the Marburg virus. In their study, which was reported in the April 27th issue of The Lancet, the researchers infected five rhesus monkeys with the Marburg virus and then injected them with the vaccine 20 to 30 minutes later. They used three other monkeys as controls infected them with the virus but were given a vaccine without the Marburg protein. They found that all five monkeys that received the Marburg protein vaccine survived for at least 80 days, while the controls died within 12 days.

Geisbert, whose team worked with colleagues at the National Microbiology Laboratory at the Public Health Agency of Canada, said that the team were very surprised at the results but stated that it may be a while before the vaccine is tested in people but he hoped it is a first step. He said that if the vaccine was so effective in monkeys given high doses of virus, it should be effective in an outbreak scenario in which people typically get lower doses.

The Ebola virus, like the Marburg causes internal bleeding at multiple sites causing hemorrhagic fever and victims usually die of multiple organ failure and shock. Both viruses are considered to be potential bio terrorism threats. Currently there are no drugs to fight infection with Marburg virus or the Ebola, both of which are caused by a family of viruses known as filoviruses, and even treatment aimed at easing the illness
'"/>




Page: 1 2

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Abortion, Bishops, and Healthcare: Announcing 'Deaf at the Cathedral' Tour in Nine States. 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 3Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 4Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 5Health News:Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year 2Health News:Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year 3Health News:LCA-Vision Joins Forces With the Wounded Warrior Project to Give the Gift of Enhanced Vision to Wounded American Heroes 2Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 2Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 3Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 4
Other Medicine News:Health News:AMN Healthcare Reports Second Quarter 2008 Results 2Health News:AMN Healthcare Reports Second Quarter 2008 Results 3Health News:AMN Healthcare Reports Second Quarter 2008 Results 4Health News:AMN Healthcare Reports Second Quarter 2008 Results 5Health News:AMN Healthcare Reports Second Quarter 2008 Results 6Health News:AMN Healthcare Reports Second Quarter 2008 Results 7Health News:AMN Healthcare Reports Second Quarter 2008 Results 8Health News:AMN Healthcare Reports Second Quarter 2008 Results 9Health News:AMN Healthcare Reports Second Quarter 2008 Results 10Health News:AMN Healthcare Reports Second Quarter 2008 Results 11Health News:AMN Healthcare Reports Second Quarter 2008 Results 12Health News:AMN Healthcare Reports Second Quarter 2008 Results 13Health News:Washington Dental Service Encourages Dental Checkups as Part of Back-to-School Routine 2Health News:Washington Dental Service Encourages Dental Checkups as Part of Back-to-School Routine 3Health News:Ortho-McNeil initiates first-of-its-kind skin infection registry 2Health News:Americans Drinking Less Alcohol 2Health News:Comar, Inc. Launches AccuCup(TM) - A Printed Dosage Cup for Use in General and Pediatric Markets 2Health News:Researchers Find Genes That Influence West Nile Virus 2Health News:Researchers Find Genes That Influence West Nile Virus 3
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Gu 58183 1Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Gu 58183 2Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Gu 58183 3Right to Health Care Debated at New ProCon org Website 58181 1Right to Health Care Debated at New ProCon org Website 58181 2R Kerry Clark and Robert J Palmisano Join Bausch 26 Lomb Board of Directors 58179 1R Kerry Clark and Robert J Palmisano Join Bausch 26 Lomb Board of Directors 58179 2